Cargando…

Mutation analysis of the MSMB gene in familial prostate cancer

BACKGROUND: MSMB, a gene coding for β-microseminoprotein, has been identified as a candidate susceptibility gene for prostate cancer (PrCa) in two genome-wide association studies (GWAS). SNP rs10993994 is 2 bp upstream of the transcription initiation site of MSMB and was identified as an associated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kote-Jarai, Z, Leongamornlert, D, Tymrakiewicz, M, Field, H, Guy, M, Al Olama, A A, Morrison, J, O'Brien, L, Wilkinson, R, Hall, A, Sawyer, E, Muir, K, Hamdy, F, Donovan, J, Neal, D, Easton, D, Eeles, R
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2010
Materias:	Genetics and Genomics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2816656/ https://www.ncbi.nlm.nih.gov/pubmed/19997100 http://dx.doi.org/10.1038/sj.bjc.6605485

Ejemplares similares

A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancer
por: Kote-Jarai, Z, et al.
Publicado: (2009)

BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients
por: Kote-Jarai, Z, et al.
Publicado: (2011)

Germline BRCA1 mutations increase prostate cancer risk
por: Leongamornlert, D, et al.
Publicado: (2012)

Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced disease
por: Leongamornlert, D, et al.
Publicado: (2014)

Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcript
por: Kote-Jarai, Z., et al.
Publicado: (2011)

Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype
por: Mitra, A, et al.
Publicado: (2008)

Glutathione-S-transferase M1, T1 and P1 polymorphisms, and breast cancer risk, in BRCA1/2 mutation carriers
por: Kadouri, L, et al.
Publicado: (2008)

Telomere Length Shows No Association with BRCA1 and BRCA2 Mutation Status
por: Killick, Emma, et al.
Publicado: (2014)

Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis
por: Edwards, S M, et al.
Publicado: (2010)

A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers
por: Kadouri, L, et al.
Publicado: (2004)

Reply: ‘Hand pattern indicates risk of prostate cancer’
por: Rahman, A A, et al.
Publicado: (2011)

Hand pattern indicates prostate cancer risk
por: Rahman, A A, et al.
Publicado: (2011)

LocusExplorer: a user-friendly tool for integrated visualization of human genetic association data and biological annotations
por: Dadaev, Tokhir, et al.
Publicado: (2016)

Common genetic variants associated with disease from genome-wide association studies are mutually exclusive in prostate cancer and rheumatoid arthritis
por: Orozco, Gisela, et al.
Publicado: (2013)

Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis
por: Pashayan, Nora, et al.
Publicado: (2015)

Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array
por: Saunders, Edward J, et al.
Publicado: (2016)

BRCA1, BRCA2 and their possible function in DNA damage response
por: Kote-Jarai, Z, et al.
Publicado: (1999)

Increased level of chromosomal damage after irradiation of lymphocytes from BRCA1 mutation carriers
por: Kote-Jarai, Z, et al.
Publicado: (2006)

Germline DNA Repair Gene Mutations in Young-onset Prostate Cancer Cases in the UK: Evidence for a More Extensive Genetic Panel
por: Leongamornlert, Daniel A., et al.
Publicado: (2019)

CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers
por: Kadouri, L, et al.
Publicado: (2001)

FK228 from Burkholderia thailandensis MSMB43
por: Liu, Xiang-Yang, et al.
Publicado: (2012)

Polygenic susceptibility to prostate and breast cancer: implications for personalised screening
por: Pashayan, N, et al.
Publicado: (2011)

Diagnostic radiation procedures and risk of prostate cancer
por: Myles, P, et al.
Publicado: (2008)

ATM polymorphisms as risk factors for prostate cancer development
por: Angèle, S, et al.
Publicado: (2004)

Identification of Germline Genetic Variants that Increase Prostate Cancer Risk and Influence Development of Aggressive Disease
por: Saunders, Edward J., et al.
Publicado: (2021)

The rs10993994 in the proximal MSMB promoter region is a functional polymorphism in Asian Indian subjects
por: Mhatre, Deepa R, et al.
Publicado: (2015)

Multistate Model Builder (MSMB): a flexible editor for compact biochemical models
por: Palmisano, Alida, et al.
Publicado: (2014)

Association between Prostinogen (KLK15) Genetic Variants and Prostate Cancer Risk and Aggressiveness in Australia and a Meta-Analysis of GWAS Data
por: Batra, Jyotsna, et al.
Publicado: (2011)

A novel MSMB-related microprotein in the postovulatory egg coats of marsupials
por: Frankenberg, Stephen, et al.
Publicado: (2011)

MSMB gene rs10993994 polymorphism increases the risk of prostate cancer
por: Peng, Tao, et al.
Publicado: (2017)

Rapidly evolving marmoset MSMB genes are differently expressed in the male genital tract
por: Lundwall, Åke, et al.
Publicado: (2009)

Cyclo(-l-prolyl-l-valinyl-) from Burkholderia thailandensis MSMB43
por: Liu, Xiang-Yang, et al.
Publicado: (2012)

HPC2/ELAC2 polymorphisms and prostate cancer risk: analysis by age of onset of disease
por: Meitz, J C, et al.
Publicado: (2002)

Association Analysis of PRKAA2 and MSMB Polymorphisms and Growth Traits of Xiangsu Hybrid Pigs
por: Xu, Jiali, et al.
Publicado: (2022)

BRCA1, BRCA2 and pedigree genetic analysis to determine genetic risk in the UK Royal Marsden Hospital tamoxifen prevention trial
por: Kote-Jarai, Z, et al.
Publicado: (2000)

Analysis of the 10q11 Cancer Risk Locus Implicates MSMB and NCOA4 in Human Prostate Tumorigenesis
por: Pomerantz, Mark M., et al.
Publicado: (2010)

Rare germline variants in DNA repair genes and the angiogenesis pathway predispose prostate cancer patients to develop metastatic disease
por: Mijuskovic, Martina, et al.
Publicado: (2018)

Correction: Rare germline variants in DNA repair genes and the angiogenesis pathway predispose prostate cancer patients to develop metastatic disease
por: Mijuskovic, Martina, et al.
Publicado: (2019)

Polygenic risk-tailored screening for prostate cancer: A benefit–harm and cost-effectiveness modelling study
por: Callender, Tom, et al.
Publicado: (2019)

Alterations in LMTK2, MSMB and HNF1B gene expression are associated with the development of prostate cancer
por: Harries, Lorna W, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_m6mv4k545rp2ct236rjke68hia